Nanba E, Tsuji A, Omura K, Suzuki Y
Division of Inherited Metabolic Disease, National Institute of Neuroscience, Tokyo, Japan.
Biochem Biophys Res Commun. 1988 Apr 29;152(2):794-800. doi: 10.1016/s0006-291x(88)80108-6.
Biosynthesis and early processing of beta-galactosidase were analyzed by pulse-chase technique in human fibroblasts. In normal cells, an 84 kDa precursor was processed first to an intermediate form of higher molecular weight (88 kDa), and then to a 64 kDa mature enzyme. This intermediate form was detected also in the culture medium. Biosynthesis of the precursor was apparently normal in four cases of GM1-gangliosidosis, and a precursor of abnormally high molecular weight (86 kDa) was observed in one case. No further processing occurred to the 88 kDa form. It was concluded that the enzyme deficiency was caused by heterogeneous molecular mutations of beta-galactosidase with a defect in early processing in this disease.
采用脉冲追踪技术在人成纤维细胞中分析了β-半乳糖苷酶的生物合成及早期加工过程。在正常细胞中,一种84 kDa的前体首先加工为较高分子量的中间形式(88 kDa),然后再加工为64 kDa的成熟酶。这种中间形式在培养基中也能检测到。在4例GM1神经节苷脂沉积症患者中,前体的生物合成显然正常,在1例患者中观察到分子量异常高(86 kDa)的前体。88 kDa形式的蛋白没有进一步加工。得出的结论是,该酶缺乏是由β-半乳糖苷酶的异质性分子突变导致的,这种突变在该疾病的早期加工过程中存在缺陷。